Syngene International Ltd.
Healthcare
Biocon to sell 10% stake in IVFA-backed R&D arm Syngene through offer-for-sale
Biopharmaceutical major Biocon Ltd's research and development arm Syngene International Ltd has filed draft red herring prospectus (DRHP) with securities ......
Healthcare
Biocon's arm Syngene appoints Peter Bains as CEO
Syngene International, a subsidiary of biopharmaceutical major Biocon Ltd, has appointed Peter Bains as chief operating officer, as per a ......
Healthcare
Biocon plans IPO for IVFA-backed drug discovery services arm Syngene
Biocon Ltd is looking to offload up to 15 per cent in its research arm Syngene International, a firm in ......
Healthcare
India Value Fund buying 10% in Biocon's research arm Syngene for $62M
Mid-market buyout specialist private equity firm India Value Fund Advisors (IVFA) is picking 10 per cent stake in Syngene International ......
Healthcare
Biocon subsidiary Syngene International looking to raise over $50M
Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News